“Activation of c-JUN modulates the transcriptional activity of CD63 serving as a novel target for the treatment of desmoid type fibromatosis”

© Desmoid Tumor Research Foundation (DTRF) | c/o CliftonLarsonAllen LLP, 50 Tice Blvd, Suite 175, Woodcliff Lake, NJ 07677
Registered 501(c)(3). EIN: 61-1493017

• Privacy Policy
• State Disclosures
• Terms of Use
• Cookie Policy